Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Smith

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Msystems|November 29, 2022
Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic PotentialA E Shea, A E Frick-Cheng, S N Smith, et al.
Oncology Research|June 22, 2001
Indoloquinoxaline compounds that selectively antagonize P-glycoproteinC D Smith, C B Myers, J T Zilfou, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1996
Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systemsM D Coleman, S N Smith, D E Kelly, et al.
Journal of Applied Microbiology|November 18, 2004
Analysis of Acanthamoeba polyphaga surface carbohydrate exposure by FITC-lectin binding and fluorescence evaluationE A G Elloway, R A Armstrong, R A Bird, et al.
Neurology|September 29, 2004
Status epilepticus after the initial diagnosis of epilepsy in childrenA T Berg, S Shinnar, F M Testa, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Altered motility in response to iron-limitation is regulated by <i>lpdA</i> in uropathogenic <i>E. coli</i> CFT073A E Frick-Cheng, A E Shea, J R Roberts, et al.
Mbio|June 14, 2024
Iron limitation induces motility in uropathogenic <i>E. coli</i> CFT073 partially through action of LpdAA E Frick-Cheng, A E Shea, J R Roberts, et al.
Mbio|June 26, 2026
Importance of manganese uptake in uropathogenic <i>Escherichia coli</i> CFT073 during urinary tract infectionA E Frick-Cheng, O O Adesunloro, B Cobine, et al.
The American Journal of Physiology|March 5, 1998
Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant miceS N Smith, S J Delaney, J R Dorin, et al.
Gene Therapy|September 1, 1996
A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correctionJ R Dorin, R Farley, S Webb, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Msystems|November 29, 2022
Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic PotentialA E Shea, A E Frick-Cheng, S N Smith, et al.
Oncology Research|June 22, 2001
Indoloquinoxaline compounds that selectively antagonize P-glycoproteinC D Smith, C B Myers, J T Zilfou, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1996
Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systemsM D Coleman, S N Smith, D E Kelly, et al.
Journal of Applied Microbiology|November 18, 2004
Analysis of Acanthamoeba polyphaga surface carbohydrate exposure by FITC-lectin binding and fluorescence evaluationE A G Elloway, R A Armstrong, R A Bird, et al.
Neurology|September 29, 2004
Status epilepticus after the initial diagnosis of epilepsy in childrenA T Berg, S Shinnar, F M Testa, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Altered motility in response to iron-limitation is regulated by <i>lpdA</i> in uropathogenic <i>E. coli</i> CFT073A E Frick-Cheng, A E Shea, J R Roberts, et al.
Mbio|June 14, 2024
Iron limitation induces motility in uropathogenic <i>E. coli</i> CFT073 partially through action of LpdAA E Frick-Cheng, A E Shea, J R Roberts, et al.
Mbio|June 26, 2026
Importance of manganese uptake in uropathogenic <i>Escherichia coli</i> CFT073 during urinary tract infectionA E Frick-Cheng, O O Adesunloro, B Cobine, et al.
The American Journal of Physiology|March 5, 1998
Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant miceS N Smith, S J Delaney, J R Dorin, et al.
Gene Therapy|September 1, 1996
A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correctionJ R Dorin, R Farley, S Webb, et al.
Pageof 5